Acquired resistance to: Cal101
DAUDI cells
Human DAUDI cells were isolated from the peripheral blood of a patient with Burkitt’s Lymphoma.
Tumour growth in vivo
The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of NXG mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing DAUDI tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.
Figure 1: (View PDF)
Tumour growth curve of the DAUDI cells as subcutaneous tumors, Mean ± SEM